Elekta AB (publ)
STO:EKTA B

Watchlist Manager
Elekta AB (publ) Logo
Elekta AB (publ)
STO:EKTA B
Watchlist
Price: 63.1 SEK 2.1% Market Closed
Market Cap: 24.1B SEK
Have any thoughts about
Elekta AB (publ)?
Write Note

Elekta AB (publ)
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Elekta AB (publ)
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Elekta AB (publ)
STO:EKTA B
Income from Continuing Operations
kr1.3B
CAGR 3-Years
1%
CAGR 5-Years
2%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Income from Continuing Operations
kr193.3m
CAGR 3-Years
86%
CAGR 5-Years
99%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Income from Continuing Operations
kr150.2m
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
17%
Getinge AB
STO:GETI B
Income from Continuing Operations
kr2.4B
CAGR 3-Years
-9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Income from Continuing Operations
kr480m
CAGR 3-Years
-3%
CAGR 5-Years
10%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Income from Continuing Operations
kr50.9m
CAGR 3-Years
52%
CAGR 5-Years
16%
CAGR 10-Years
44%
No Stocks Found

Elekta AB (publ)
Glance View

Market Cap
24.1B SEK
Industry
Health Care

Elekta AB operates as a medical technology company. The company is headquartered in Stockholm, Stockholm and currently employs 4,591 full-time employees. The firm offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. The firm has four product areas: Elekta Neuroscience, which develops solutions for the diagnosis and treatment of neurological diseases; Elekta Oncology, which creates clinical solutions for radiation therapy, such as linear accelerators, integrated imaging systems and clinical solutions for patient positioning and immobilization; Elekta Brachytherapy, which is engaged in the treatment of cancer through internal radiation, and Elekta Software, which develops software solutions for patient information, workflow management and treatment planning in oncology. The firm owns the service business of Asesores Electronicos Especializados SA de CV (AEESA).

EKTA B Intrinsic Value
96.12 SEK
Undervaluation 34%
Intrinsic Value
Price

See Also

What is Elekta AB (publ)'s Income from Continuing Operations?
Income from Continuing Operations
1.3B SEK

Based on the financial report for Apr 30, 2024, Elekta AB (publ)'s Income from Continuing Operations amounts to 1.3B SEK.

What is Elekta AB (publ)'s Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
2%

Over the last year, the Income from Continuing Operations growth was 38%. The average annual Income from Continuing Operations growth rates for Elekta AB (publ) have been 1% over the past three years , 2% over the past five years .

Back to Top